These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 16896037

  • 1. The cost of prostate cancer chemoprevention: a decision analysis model.
    Svatek RS, Lee JJ, Roehrborn CG, Lippman SM, Lotan Y.
    Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1485-9. PubMed ID: 16896037
    [Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness of prostate cancer chemoprevention: a quality of life-years analysis.
    Svatek RS, Lee JJ, Roehrborn CG, Lippman SM, Lotan Y.
    Cancer; 2008 Mar 01; 112(5):1058-65. PubMed ID: 18186497
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Do the benefits of finasteride outweigh the risks in the prostate cancer prevention trial?
    Grover S, Lowensteyn I, Hajek D, Trachtenberg J, Coupal L, Marchand S.
    J Urol; 2006 Mar 01; 175(3 Pt 1):934-8; discussion 938. PubMed ID: 16469585
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [The PCPT trial].
    Hamdy FC, Rouprêt M.
    Prog Urol; 2008 Apr 01; 18 Suppl 3():S40-3. PubMed ID: 18455082
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Decision analysis of tamoxifen for the prevention of invasive breast cancer.
    Grann VR, Sundararajan V, Jacobson JS, Whang W, Heitjan DF, Antman KH, Neugut AI.
    Cancer J; 2000 Apr 01; 6(3):169-78. PubMed ID: 10882333
    [Abstract] [Full Text] [Related]

  • 18. Should we screen for bladder cancer in a high-risk population?: A cost per life-year saved analysis.
    Lotan Y, Svatek RS, Sagalowsky AI.
    Cancer; 2006 Sep 01; 107(5):982-90. PubMed ID: 16862567
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.